Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zucchetti

Showing results (371-380 of 479) with videos related to

Pageof 48
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|November 24, 2020
Metabolic brain changes across different levels of cognitive impairment in ALS: a <sup>18</sup>F-FDG-PET studyAntonio Canosa, Cristina Moglia, Umberto Manera, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 11, 2021
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical modelsLavinia Morosi, Marina Meroni, Paolo Ubezio, et al.
Nature Communications|June 30, 2019
Tethering of vesicles to the Golgi by GMAP210 controls LAT delivery to the immune synapseAndres Ernesto Zucchetti, Laurence Bataille, Jean-Marie Carpier, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 11, 2018
Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedinUmberto Capasso Palmiero, Lavinia Morosi, Ezia Bello, et al.
ACS Nano|August 16, 2017
Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular ReleaseDaniele Maiolo, Claudia Pigliacelli, Paola Sánchez Moreno, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2008
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancerC Sessa, A Perotti, C Noberasco, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 15, 2021
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activityDenise Pinessi, Andrea Resovi, Fabio Sangalli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complexC Sessa, G Capri, L Gianni, et al.
International Journal of Molecular Sciences|November 18, 2016
Characterizing Non-Tuberculous Mycobacteria Infection in BronchiectasisPaola Faverio, Anna Stainer, Giulia Bonaiti, et al.
Journal of the National Cancer Institute|October 19, 2000
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571C Gambacorti-Passerini, R Barni, P le Coutre, et al.
Pageof 48

Showing results (371-380 of 479) with videos related to

Sort By:
Pageof 48
Journal of Neurology, Neurosurgery, and Psychiatry|November 24, 2020
Metabolic brain changes across different levels of cognitive impairment in ALS: a <sup>18</sup>F-FDG-PET studyAntonio Canosa, Cristina Moglia, Umberto Manera, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 11, 2021
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical modelsLavinia Morosi, Marina Meroni, Paolo Ubezio, et al.
Nature Communications|June 30, 2019
Tethering of vesicles to the Golgi by GMAP210 controls LAT delivery to the immune synapseAndres Ernesto Zucchetti, Laurence Bataille, Jean-Marie Carpier, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 11, 2018
Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedinUmberto Capasso Palmiero, Lavinia Morosi, Ezia Bello, et al.
ACS Nano|August 16, 2017
Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular ReleaseDaniele Maiolo, Claudia Pigliacelli, Paola Sánchez Moreno, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2008
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancerC Sessa, A Perotti, C Noberasco, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 15, 2021
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activityDenise Pinessi, Andrea Resovi, Fabio Sangalli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complexC Sessa, G Capri, L Gianni, et al.
International Journal of Molecular Sciences|November 18, 2016
Characterizing Non-Tuberculous Mycobacteria Infection in BronchiectasisPaola Faverio, Anna Stainer, Giulia Bonaiti, et al.
Journal of the National Cancer Institute|October 19, 2000
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571C Gambacorti-Passerini, R Barni, P le Coutre, et al.
Pageof 48